BCTX generated another new all-time weekly closing low at 1.97, meaning that it dropped over 32% in price this past week. The reason for the price drop is that the company is considering another (3rd this year) public offering of close to 7 million shares at 2.93. The company has faced increased costs and negative earnings recently, and requires funds to continue its cancer studies that promise a bright future, especially considering that several of the medicines they are working on have shown very promising results. The stock closed near the low of the week and further downside below 1.97 is expected to be seen this week. Pivotal intraweek resistance is at 3.15. Nonetheless, in looking at the intraday chart, a rally above 2.18 would generate some new buying interest. Having said that, it is unlikely the stock will generate any kind of a rally until the public offering is announced and completed. By the same token, the public offering (if it happens) is at 2.93, meaning that at 1.97, it is below that price.

LXRX generated a new 32-week intraweek and weekly closing high and closed near the high of the week, suggesting further upside above last week's high at 1.19 will be seen this week. The next area of weekly close resistance is found between 1.48 and 1.58, meaning that is the target for this week. On a daily closing basis, support is now found at .99. Fundamental analysts on the stock have predicted a $4 target for this year.

TCEHY generated a new 6-week intraweek low and closed near the low of the week, suggesting further downside below last week's low at 62.71 will be seen this week. No new signals were given, meaning that the bears remain with the edge but did not gain any new ammunition. A daily close below 62.35 would generate a new sell signal, as well as a failure signal of consequence, giving a downside target of reaching the 200-day MA, currently at 58.58. To the upside, a daily close above 63.98 would take some of the bear's edge away.

TXN generated a new all-time intraweek, daily and weekly closing high and closed on the high of the week, suggesting further upside above last week's high at 221.69 will be seen this week. The bulls will need to confirm the breakout and that could be done on Wednesday's daily close, given that the company reports earnings on Tuesday after the close. Earnings are expected to be higher than last year (expected to be $1.34, vs last year's $1.17). If that occurs, covering of the short positions will be a must. Any daily close below the previous all-time high daily close at 220.29 will be seen as a negative (stock closed on Friday at 221.25).

VWDRY generated an uneventful inside week but did close on the low of the week, suggesting further downside below last week's low at 5.44 will be seen this week. The stock did generate a minor sell signal on the daily closing chart, having closed below the previous low daily close at 5.47 (closed at 5.44). This does suggest that on an intraweek basis, the 200-day MA (currently at 5.13) could be visited. A daily close above 5.70 would negate this week's downside outlook and a daily close above 5.84 would give the bulls new ammunition.

YUMC generated a new 13-week intraweek and weekly closing high and closed near the high of the week, suggesting further upside above last week's high at 48.36 will be seen this week. On a potential negative, the stock fell back (from the high) on Friday to close exactly at the 200-week MA (currently at 47.71 - stock closed on Friday at 47.72) and that was the upside objective after the stock started the current rally 3 weeks ago. It is unlikely that the bulls will be successful on any kind of a breakout above that line until the company reports earnings on the 31st. On an intraweek basis, there is no resistance above until 51.72, meaning that if the bulls can pull "a rabbit out of the hat", that would be the objective. The 200-day MA is currently at 46.54 and that is Monday's objective. A daily close below that level will not only break the line but also generate a failure signal against the bulls, meaning that line and the previous high daily close at 46.91 are short-term pivotal this week. A red weekly close next Friday would suggest that 45.56 would be the minimum objective.

ZLAB generated a new 5-week intraweek and weekly closing low and closed on the low of the week, suggesting further downside below last week's low at 32.31 will be seen this week. The stock did generate a sell signal on the weekly closing chart that offers a downside objective of 32.00 (based on a weekly close). On intraweek basis though, the 200-day MA, currently at 30.37, is a likely target (highly likely to be reached this week). There has been no news, meaning that this recent weakness is chart oriented and likely based on the fact that the 200-week MA (currently at 35.44) was reached (and broken) 5 weeks ago but given that it was the first time in close to 4 years, the failure to stay above it, brought in selling by the computers and algorithms. Having said that and given that there has been no change in the fundamental picture, the break of the line (for 1 week) is a positive sign, suggesting that overall and for the mid-to-long term, the stock should be heading higher. Any weekly close below 30.14 would negate this outlook.